3-Ethoxyacryloyl Chloride CAS 6191-99-7 Purity >97.0% (GC) Dasatinib Intermediate
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 3-Ethoxyacryloyl Chloride (CAS: 6191-99-7) with high quality. Ruifu Chemical can provide worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Purchase 3-Ethoxyacryloyl Chloride, Please contact: alvin@ruifuchem.com
Chemical Name | 3-Ethoxyacryloyl Chloride |
Synonyms | 3-Ethoxy-acryloyl Chloride; 3-Ethoxyacrylic Acid Chloride; b-Ethoxyacrylic Chloride; 3-Ethoxypropenoic Acid Chloride; (2E)-3-Ethoxyacryloyl Chloride |
CAS Number | 6191-99-7 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C5H7ClO2 |
Molecular Weight | 134.56 |
Boiling Point | 75℃/10 mmHg |
Flash Point | 25℃ |
Density | 1.125±0.06 g/cm3 |
Refractive Index n20/D | 1.4860 to 1.4910 |
Store Under Inert Gas | Store Under Inert Gas |
Sensitive | Moisture Sensitive, Heat Sensitive |
COA & MSDS | Available |
Origin of Product | Shanghai, China |
Product Categories | Pharmaceutical Intermediates |
Brand | Ruifu Chemical |
Item | Specifications | Specifications |
Appearance | Light Yellow Liquid | Light Yellow Liquid |
3-Ethoxyacryloyl Chloride | >97.0% (GC) | 98.67% (GC) |
Water (by Karl Fischer) | <0.50% | 0.13% |
Infrared Spectrum | Conforms to Structure | Conforms |
Test Standard | Enterprise Standard | Conforms |
Package: Fluorinated Bottle, 25kg/Barrel, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
How to Purchase? Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Russia, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Hazard Symbols C - Corrosive
Risk Codes R10 - Flammable
R22 - Harmful if swallowed
R34 - Causes burns
R42/43 - May cause sensitization by inhalation and skin contact.
Safety Description S23 - Do not breathe vapour.
S24 - Avoid contact with skin.
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
UN IDs UN2920 8/PG 2
3-Ethoxyacryloyl Chloride (CAS: 6191-99-7) can be used as an intermediate in organic synthesis and medicine, and is mainly used in laboratory research and development process and chemical production process.
Dasatinib can be synthesized from 3-Ethoxyacryloyl Chloride by acylation, cyclization and nucleophilic substitution.
Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body. Dasatinib, previously known as BMS-354825, Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).